184 related articles for article (PubMed ID: 15700847)
1. Incidence and management of proven and probable fungal infections in patients with acute leukemia: a single center experience.
Fanci R; Casini C; Leoni F; Ciolli S; Bosi A
J Chemother; 2004 Dec; 16(6):557-60. PubMed ID: 15700847
[TBL] [Abstract][Full Text] [Related]
2. Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections. Evaluation of United Kingdom compassionate use data.
Ng TT; Denning DW
Arch Intern Med; 1995 May; 155(10):1093-8. PubMed ID: 7748054
[TBL] [Abstract][Full Text] [Related]
3. Proven and probable invasive fungal infections in children with acute lymphoblastic leukaemia: results from an university hospital, 2005-2013.
Sahbudak Bal Z; Yilmaz Karapinar D; Karadas N; Sen S; Onder Sivis Z; Akinci AB; Balkan C; Kavakli K; Vardar F; Aydinok Y
Mycoses; 2015 Apr; 58(4):225-32. PubMed ID: 25728069
[TBL] [Abstract][Full Text] [Related]
4. Risks and outcome of fungal infection in neutropenic children with hematologic diseases.
Aytaç S; Yildirim I; Ceyhan M; Cetin M; Tuncer M; Kara A; Cengiz AB; Seçmeer G; Yetgin S
Turk J Pediatr; 2010; 52(2):121-5. PubMed ID: 20560245
[TBL] [Abstract][Full Text] [Related]
5. Successful control of Blastoschizomyces capitatus infection in three consecutive acute leukaemia patients despite initial unresponsiveness to liposomal amphotericin B.
Adami F; Scarin M; Pescarini L; Binotto G; Pavan L; Sgarabotto D; Semenzato G
Mycoses; 2011 Jul; 54(4):365-9. PubMed ID: 20406399
[No Abstract] [Full Text] [Related]
6. Amphotericin B treatment of fungemia due to unusual pathogens in neutropenic patients: report of two cases.
Fanci R; Pecile P; Martinez RL; Fabbri A; Nicoletti P
J Chemother; 1997 Dec; 9(6):427-30. PubMed ID: 9491843
[TBL] [Abstract][Full Text] [Related]
7. Liposomal amphotericin B (AmBisome) efficacy in confirmed invasive aspergillosis and other filamentous fungal infections in immunocompromised hosts: a pooled analysis.
Cordonnier C; Bresnik M; Ebrahimi R
Mycoses; 2007 May; 50(3):205-9. PubMed ID: 17472618
[TBL] [Abstract][Full Text] [Related]
8. Liposomal amphotericin B as early empiric antimycotic therapy of pneumonia in granulocytopenic patients.
Böhme A; Hoelzer D
Mycoses; 1996; 39(11-12):419-26. PubMed ID: 9144997
[TBL] [Abstract][Full Text] [Related]
9. Liposomal amphotericin B (AmBisome) for fungal infections in immunocompromised adults and children.
Tollemar J; Klingspor L; Ringdén O
Clin Microbiol Infect; 2001; 7 Suppl 2():68-79. PubMed ID: 11525221
[TBL] [Abstract][Full Text] [Related]
10. Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy.
Park H; Youk J; Shin DY; Hong J; Kim I; Kim NJ; Lee JO; Bang SM; Yoon SS; Park WB; Koh Y
BMC Cancer; 2019 Apr; 19(1):358. PubMed ID: 30991992
[TBL] [Abstract][Full Text] [Related]
11. Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients.
Chopra R; Blair S; Strang J; Cervi P; Patterson KG; Goldstone AH
J Antimicrob Chemother; 1991 Oct; 28 Suppl B():93-104. PubMed ID: 1778896
[TBL] [Abstract][Full Text] [Related]
12. Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.
De la Serna J; Jarque I; López-Jiménez J; Fernández-Navarro JM; Gómez V; Jurado M; Pascual A; Serrano J; Romero M; Vallejo C
Rev Esp Quimioter; 2013 Mar; 26(1):64-9. PubMed ID: 23546466
[TBL] [Abstract][Full Text] [Related]
13. Focus on fungal infections.
MacDougall DS
J Int Assoc Physicians AIDS Care; 1997 Jul; 3(7):27-32. PubMed ID: 11364470
[TBL] [Abstract][Full Text] [Related]
14. Low-dose amphotericin for prevention of serious fungal infection following liver transplantation.
Shah T; Lai WK; Gow P; Leeming J; Mutimer D
Transpl Infect Dis; 2005; 7(3-4):126-32. PubMed ID: 16390401
[TBL] [Abstract][Full Text] [Related]
15. Invasive fungal infections in patients with acute leukemia.
Hsiao HH; Tsai HJ; Liu YC; Tseng YT; Lu PL; Yang WC; Liu TC; Lin SF
Kaohsiung J Med Sci; 2006 May; 22(5):217-22. PubMed ID: 16793556
[TBL] [Abstract][Full Text] [Related]
16. Use of liposomal amphotericin B in bone marrow transplant.
Sastry PS; Parikh PM; Kulkarni PS; Bhagwat R; Gadade H
J Postgrad Med; 2005; 51 Suppl 1():S49-52. PubMed ID: 16519256
[TBL] [Abstract][Full Text] [Related]
17. Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B.
Offner F; Krcmery V; Boogaerts M; Doyen C; Engelhard D; Ribaud P; Cordonnier C; de Pauw B; Durrant S; Marie JP; Moreau P; Guiot H; Samonis G; Sylvester R; Herbrecht R;
Antimicrob Agents Chemother; 2004 Dec; 48(12):4808-12. PubMed ID: 15561860
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients.
Ringdén O; Meunier F; Tollemar J; Ricci P; Tura S; Kuse E; Viviani MA; Gorin NC; Klastersky J; Fenaux P
J Antimicrob Chemother; 1991 Oct; 28 Suppl B():73-82. PubMed ID: 1778894
[TBL] [Abstract][Full Text] [Related]
19. Systemic mycoses during prophylactical use of liposomal amphotericin B (Ambisome) after liver transplantation.
Lorf T; Braun F; Rüchel R; Müller A; Sattler B; Ringe B
Mycoses; 1999 Apr; 42(1-2):47-53. PubMed ID: 10394848
[TBL] [Abstract][Full Text] [Related]
20. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
Walsh TJ; Finberg RW; Arndt C; Hiemenz J; Schwartz C; Bodensteiner D; Pappas P; Seibel N; Greenberg RN; Dummer S; Schuster M; Holcenberg JS
N Engl J Med; 1999 Mar; 340(10):764-71. PubMed ID: 10072411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]